PATENT CLAIM ANALYSIS

Application Number: 16412804
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 42):
A method for preparing a co-crystal of  claim 30 , the method comprising:\n (i) mixing the N-trimethylglycine and the co-former in a solvent at a temperature of about 40-110\u00b0 C. to form a saturated solution; (ii) incubating the solution at a temperature of about 40-110\u00b0 C. for 1-10 hours; (iii) cooling the solution at a temperature of about 4-30\u00b0 C. for 10-36 hours to allow formation of the co-crystal; and (iv) collecting the co-crystal formed in (iii), wherein the solvent is selected from the group consisting of methanol, ethanol, acetic acid, dimethyl sulfoxide, tetrahydrofuran, water, and diethyl ether, or a combination thereof.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 100.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15944722', '15866303', '15430750', '16130836', '15188545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.747889406634343
- 35 USC 102 Novelty (BERT): 0.5817343890934106
- Combined Prediction Score: 0.7312739048802497
- Mean Citation Score: 386.35124400000007
- Max Citation Score: 461.1239
- Similarity Product: 443.81074411948913

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test